Alle Fotos(1)

Key Documents

Ursprungszeugnis (CoO)/Analysenzertifikate (CoA)

View All Documentation

1123000

USP

Chlorpheniraminmaleat

Name: Chlorpheniraminmaleat
Brand: USP

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

(±)-Chlorpheniramin -maleat (Salz)

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):

C₁₆H₁₉ClN₂ · C₄H₄O₄

CAS-Nummer:

113-92-8

Molekulargewicht:

390.86

MDL-Nummer:

MFCD00069225

UNSPSC-Code:

41116107

PubChem Substanz-ID:

329749337

NACRES:

NA.24

Empfohlene Produkte

Slide 1 of 10

1 of 10

Supelco

PHR1016

Chlorpheniramin-Maleat

C1800000

Chlorphenaminmaleat

Supelco

PHR1005

4-Acetamidophenol

USP

1003009

Acetaminophen

Supelco

PHR1018

Dextromethorphan HBr

USP

1123135

Chlorpheniramin-verwandte Verbindung B

Supelco

PHR1009

Koffein

BP371

Paracetamol

Supelco

PHR1688

Chlorpheniramin-verwandte Verbindung C

USP

1218005

Diphenhydramin -hydrochlorid

Qualität

pharmaceutical primary standard

API-Familie

chlorpheniramine

Hersteller/Markenname

USP

mp (Schmelzpunkt)

130-135 °C (lit.)

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

CN(C)CCC(C1=CC=C(Cl)C=C1)C2=NC=CC=C2.O=C(/C=C\C(O)=O)O

InChI

1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-

InChIKey

DBAKFASWICGISY-BTJKTKAUSA-N

Angaben zum Gen

human ... HRH1(3269)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Chlorpheniramine maleate USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Chlorpheniramine Maleate Tablets
Chlorpheniramine Maleate Oral Solution
Chlorpheniramine Maleate Extended-Release Capsules
Chlorpheniramine Maleate and Pseudoephedrine Hydrochloride Oral Solution
Acetaminophen, Chlorpheniramine Maleate, and Dextromethorphan Hydrobromide Tablets
Chlorpheniramine Maleate and Pseudoephedrine Hydrochloride Extended-Release Capsules
Penicillin G Procaine, Dihydrostreptomycin Sulfate, Chlorpheniramine Maleate, and Dexamethasone Injectable Suspension

Biochem./physiol. Wirkung

H₁ Histamin-Rezeptorantagonist

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Sonstige Hinweise

Sales restrictions may apply.

Signalwort

Warning

H-Sätze

H302

P-Sätze

P301 + P312 + P330

Gefahreneinstufungen

Acute Tox. 4 Oral

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 9

1 of 9

Supelco

PHR1647

Chlorpheniramin-verwandte Verbindung B

P0850000

Pheniraminmaleat

Y0000436

Chlorphenamin Unreinheit A

USP

1003009

Acetaminophen

USP

1301007

Guaifenesin

Y0001170

Ascorbinsäure Unreinheit D

Y0001024

Ascorbinsäure Unreinheit C

USP

1021204

4-Aminophenol

USP

1495005

Papain

Retrograde and Anterograde Transport of Lat-Vesicles during the Immunological Synapse Formation: Defining the Finely-Tuned Mechanism.

Juan José Saez et al.

Cells, 10(2) (2021-02-13)

LAT is an important player of the signaling cascade induced by TCR activation. This adapter molecule is present at the plasma membrane of T lymphocytes and more abundantly in intracellular compartments. Upon T cell activation the intracellular pool of LAT

Dorsal hippocampal microinjection of chlorpheniramine reverses the anxiolytic-like effects of l-histidine and impairs emotional memory in mice.

L Canto-de-Souza et al.

Neuroscience letters, 587, 11-16 (2014-12-20)

Several findings have pointed to the role of histaminergic neurotransmission in the modulation of anxiety-like behaviors and emotional memory. The elevated plus-maze (EPM) test has been widely used to investigate the process of anxiety and also has been used to

Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assay.

Cheryl C Y Loh et al.

PloS one, 9(10), e110800-e110800 (2014-10-25)

Chloroquine was a cheap, extremely effective drug against Plasmodium falciparum until resistance arose. One approach to reversing resistance is the inhibition of chloroquine efflux from its site of action, the parasite digestive vacuole. Chloroquine accumulation studies have traditionally relied on

Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.

Hao Lou et al.

Drug development and industrial pharmacy, 40(7), 910-918 (2013-04-30)

To mask the bitterness of Chlorpheniramine Maleate via encapsulating drug into Eudragit EPO microparticles, and then incorporate these microparticles into orally disintegrating films (ODF) and orally disintegrating tablets (ODT) for pediatric uses. Spray drying of water-in-oil emulsion was utilized to

Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.

Shigeru Hishinuma et al.

Biochemical pharmacology, 91(2), 231-241 (2014-07-30)

Differential binding sites for first- and second-generation antihistamines were indicated on the basis of the crystal structure of human histamine H1 receptors. In this study, we evaluated differences between the thermodynamic driving forces of first- and second-generation antihistamines for human

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.

Key Documents

Chlorpheniraminmaleat

United States Pharmacopeia (USP) Reference Standard

About This Item

Empfohlene Produkte

Eigenschaften

Qualität

API-Familie

Hersteller/Markenname

mp (Schmelzpunkt)

Anwendung(en)

Format

SMILES String

InChI

InChIKey

Angaben zum Gen

Verwandte Kategorien

Beschreibung

Allgemeine Beschreibung

Anwendung

Biochem./physiol. Wirkung

Hinweis zur Analyse

Sonstige Hinweise

Verwandte Produkte

Ähnliches Produkt

Sicherheitshinweise

Piktogramme

Signalwort

H-Sätze

P-Sätze

Gefahreneinstufungen

Lagerklassenschlüssel

WGK

Flammpunkt (°F)

Flammpunkt (°C)

Dokumentation

Analysenzertifikate (COA)

Besitzen Sie dieses Produkt bereits?

Kunden haben sich ebenfalls angesehen

Peer-Reviewed-Artikel

Technischer Dienst